Literature DB >> 26133320

Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents.

Nevzat Karabulut1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26133320      PMCID： PMC4498420          DOI： 10.5152/dir.2015.001

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN： 1305-3825            Impact factor:   2.630


× No keyword cloud information.
  12 in total

1.  The need for radiologists' awareness of nephrogenic systemic fibrosis.

Authors:  Ustün Aydingöz
Journal:  Diagn Interv Radiol       Date:  2006-12       Impact factor: 2.630

2.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

Review 3.  Contrast agents used in MR imaging of the liver.

Authors:  Nevzat Karabulut; Nevra Elmas
Journal:  Diagn Interv Radiol       Date:  2006-03       Impact factor: 2.630

4.  Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols.

Authors:  Diego R Martin; Saravanan K Krishnamoorthy; Bobby Kalb; Khalil N Salman; Puneet Sharma; John D Carew; Phillip A Martin; Arlene B Chapman; Gaye L Ray; Christian P Larsen; Thomas C Pearson
Journal:  J Magn Reson Imaging       Date:  2010-02       Impact factor: 4.813

5.  Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.

Authors:  Alexander Radbruch; Lukas D Weberling; Pascal J Kieslich; Oliver Eidel; Sina Burth; Philipp Kickingereder; Sabine Heiland; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus
Journal:  Radiology       Date:  2015-04-06       Impact factor: 11.105

6.  High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.

Authors:  Tomonori Kanda; Marie Osawa; Hiroshi Oba; Keiko Toyoda; Jun'ichi Kotoku; Takahiro Haruyama; Koji Takeshita; Shigeru Furui
Journal:  Radiology       Date:  2015-01-27       Impact factor: 11.105

7.  Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.

Authors:  Yuri Errante; Vincenzo Cirimele; Carlo Augusto Mallio; Vincenzo Di Lazzaro; Bruno Beomonte Zobel; Carlo Cosimo Quattrocchi
Journal:  Invest Radiol       Date:  2014-10       Impact factor: 6.016

8.  Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.

Authors:  Robert J McDonald; Jennifer S McDonald; David F Kallmes; Mark E Jentoft; David L Murray; Kent R Thielen; Eric E Williamson; Laurence J Eckel
Journal:  Radiology       Date:  2015-03-05       Impact factor: 11.105

9.  Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

Authors:  Peter Marckmann; Lone Skov; Kristian Rossen; Anders Dupont; Mette Brimnes Damholt; James Goya Heaf; Henrik S Thomsen
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

10.  Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.

Authors:  Tomonori Kanda; Toshio Fukusato; Megumi Matsuda; Keiko Toyoda; Hiroshi Oba; Jun'ichi Kotoku; Takahiro Haruyama; Kazuhiro Kitajima; Shigeru Furui
Journal:  Radiology       Date:  2015-05-05       Impact factor: 11.105
View more
  5 in total

1.  Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?

Authors:  Christopher Klenk; Rakhee Gawande; Vy Thao Tran; Jennifer Trinh Leung; Kevin Chi; Daniel Owen; Sandra Luna-Fineman; Kathleen M Sakamoto; Alex McMillan; Andy Quon; Heike E Daldrup-Link
Journal:  J Nucl Med       Date:  2015-10-15       Impact factor: 10.057

2.  A Metal-Free Method for Producing MRI Contrast at Amyloid-β.

Authors:  Silvia Hilt; Tang Tang; Jeffrey H Walton; Madhu Budamagunta; Izumi Maezawa; Tamás Kálai; Kálmán Hideg; Vikrant Singh; Heike Wulff; Qizhi Gong; Lee-Way Jin; Angelique Louie; John C Voss
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 3.  Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents.

Authors:  Kerry A Layne; Paul I Dargan; John R H Archer; David M Wood
Journal:  Br J Clin Pharmacol       Date:  2018-08-17       Impact factor: 4.335

4.  Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatment.

Authors:  Eric Nyberg; Justin Honce; Bette K Kleinschmidt-DeMasters; Brian Shukri; Sarah Kreidler; Lidia Nagae
Journal:  Neuroradiol J       Date:  2016-08-19

5.  Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.

Authors:  Houchun H Hu; Amber Pokorney; Richard B Towbin; Jeffrey H Miller
Journal:  Pediatr Radiol       Date:  2016-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.